Ishiura H, Doi H, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, et al. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. Nat Genet. 2018;50:581–90.
Google Scholar
Ishiura H, Tsuji S. Advances in repeat expansion diseases and a new concept of repeat motif-phenotype correlation. Curr Opin Genet Dev. 2020;65:176–85.
Google Scholar
Corbett MA, Kroes T, Veneziano L, Bennett MF, Florian R, Schneider AL, et al. Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2. Nat Commun. 2019;10:4920.
Florian RT, Kraft F, Leitão E, Kaya S, Klebe S, Magnin E, et al. Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3. Nat Commun. 2019;10:4919.
Yeetong P, Pongpanich M, Srichomthong C, Assawapitaksakul A, Shotelersuk V, Tantirukdham N, et al. TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4. Brain. 2019;142:3360–6.
Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127–30.
Google Scholar
Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51:1222–32.
Google Scholar
Deng J, Yu J, Li P, Luan X, Cao L, Zhao J, et al. Expansion of GGC repeat in GIPC1 is associated with oculopharyngodistal myopathy. Am J Hum Genet. 2020;106:793–804.
Google Scholar
Xi J, Wang X, Yue D, Dou T, Wu Q, Lu J, et al. 5’ UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy. Brain. 2021;144:601–14.
Yu J, Shan J, Yu M, Di L, Xie Z, Zhang W, et al. The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4. Am J Hum Genet. 2022;109:533–41.
Google Scholar
Ogasawara M, Iida A, Kumutpongpanich T, Ozaki A, Oya Y, Konishi H, et al. CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun. 2020;8:204.
Google Scholar
Yu J, Deng J, Guo X, Shan J, Luan X, Cao L, et al. The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. Brain. 2021;144:1819–32.
Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, et al. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet. 1992;1:341–4.
Google Scholar
Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol. 2007;6:45–55.
Google Scholar
Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 2013;12:786–98.
Google Scholar
Hagerman RJ, Hagerman P. Fragile X-associated tremor/ataxia syndrome—features, mechanisms and management. Nat Rev Neurol. 2016;12:403–12.
Google Scholar
Toko M, Ohshita T, Kurashige T, Morino H, Kume K, Yamashita H, et al. FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report. BMC Neurol. 2021;21:396.
Dombrowski C, Lévesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 2002;11:371–8.
Almansour A, Ishiura H, Mitsui J, Matsukawa T, Matsukawa MK, Shimizu H, et al. Frequency of FMR1 premutation alleles in patients with undiagnosed cerebellar ataxia and multiple system atrophy in the Japanese population. Cerebellum. 2022;21:954–962.
Higuchi Y, Ando M, Yoshimura A, Hakotani S, Koba Y, Sakiyama Y, et al. Prevalence of Fragile X-Associated Tremor/Ataxia Syndrome in Patients with Cerebellar Ataxia in Japan. Cerebellum. 2021;2:851–860.
Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB. A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol (Berl). 1968;10:54–73.
Google Scholar
Haltia M, Somer H, Palo J, Johnson WG. Neuronal intranuclear inclusion disease in identical twins. Ann Neurol. 1984;15:316–21.
Google Scholar
Kimber TE, Blumbergs PC, Rice JP, Hallpike JF, Edis R, Thompson PD, et al. Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci. 1998;160:33–40.
Google Scholar
Gelpi E, Botta-Orfila T, Bodi L, Marti S, Kovacs G, Grau-Rivera O, et al. Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma. Brain. 2017;140:e51.
Takahashi-Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology. 2003;23:351–9.
Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M, et al. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology. 2011;76:1372–6.
Google Scholar
Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H, et al. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry. 2014;85:354–6.
Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, et al. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019;51:1215–21.
Google Scholar
Tian Y, Wang J-L, Huang W, Zeng S, Jiao B, Liu Z, et al. Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders. Am J Hum Genet. 2019;105:166–76.
Google Scholar
Lim SY, Ishiura H, Ramli N, Shibata S, Almansour MA, Tan AH, et al. Adult-onset neuronal intranuclear inclusion disease mimicking Fragile X-associated tremor-ataxia syndrome in ethnic Chinese patients. Parkinsonism Relat Disord. 2020;74:25–7.
Liao YC, Chang FP, Huang HW, Chen TB, Chou YT, Hsu SL, et al. GGC Repeat Expansion of NOTCH2NLC in Taiwanese Patients With Inherited Neuropathies. Neurology 2022;98:e119–e206.
Liu YH, Chou YT, Chang FP, Lee WJ, Guo YC, Chou CT, et al. Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy. Brain. 2022;145:3010–21.
Yu WY, Xu Z, Lee HY, Tokumaru A, Tan JMM, Ng A, et al. Identifying patients with neuronal intranuclear inclusion disease in Singapore using characteristic diffusion-weighted MR images. Neuroradiology 2019;61:1281–90.
Chen Z, Yan Yau W, Jaunmuktane Z, Tucci A, Sivakumar P, Gagliano Taliun SA, et al. Neuronal intranuclear inclusion disease is genetically heterogeneous. Ann Clin Transl Neurol. 2020;7:1716–25.
Fukuda H, Yamaguchi D, Nyquist K, Yabuki Y, Miyatake S, Uchiyama Y, et al. Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing. Clin Epigenetics. 2021;13:204.
Google Scholar
Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain 2016;139:3170–86.
Nakamura N, Tsunoda K, Mitsutake A, Shibata S, Mano T, Nagashima Y et al. Clinical characteristics of neuronal intranuclear inclusion disease-related retinopathy with CGG repeat expansions in the NOTCH2NLC Gene. Invest Ophthalmol Vis Sci. 2020;61:27.
Google Scholar
Hayashi T, Katagiri S, Mizobuchi K, Yoshitake K, Kameya S, Matsuura T, et al. Heterozygous GGC repeat expansion of NOTCH2NLC in a patient with neuronal intranuclear inclusion disease and progressive retinal dystrophy. Ophthalmic Genet. 2020;41:93–5.
Google Scholar
Sugiyama A, Sato N, Kimura Y, Maekawa T, Enokizono M, Saito Y, et al. MR Imaging features of the cerebellum in adult-onset neuronal intranuclear inclusion disease: 8 cases. AJNR Am J Neuroradiol. 2017;38:2100–4.
Google Scholar
Tokimura R, Maeda MH, Mitsutake A, Sakai S, Suzuki F, Sugasawa K, et al. Isolated paravermal hyperintensities in neuronal intranuclear inclusion disease. Neurology 2022;98:938–9.
Padilha IG, Nunes RH, Scortegagna FA, Pedroso JL, Marussi VH, Rodrigues Gonçalves MR, et al. MR Imaging features of adult-onset neuronal intranuclear inclusion disease may be indistinguishable from fragile X-associated tremor/ataxia syndrome. AJNR Am J Neuroradiol. 2018;39:E100–E101.
Google Scholar
Nakano Y, Takahashi-Fujigasaki J, Sengoku R, Kanemaru K, Arai, Kanda T, et al. PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease. J Neuropathol Exp Neurol. 2017;76:585–94.
Google Scholar
Satoyoshi E, Kinoshita M. Oculopharyngodistal myopathy. Arch Neurol. 1977;34:89–92.
Google Scholar
Uyama E, Uchino M, Chateau D, Tomé FM. Autosomal recessive oculopharyngodistal myopathy in light of distal myopathy with rimmed vacuoles and oculopharyngeal muscular dystrophy. Neuromuscul Disord. 1998;8:119–25.
Google Scholar
Minami N, Ikezoe K, Kuroda H, Nakabayashi H, Satoyoshi E, Nonaka I. Oculopharyngodistal myopathy is genetically heterogeneous and most cases are distinct from oculopharyngeal muscular dystrophy. Neuromuscul Disord. 2001;11:699–702.
Google Scholar
Witoonpanich R, Phankhian S, Sura T, Lertrit P, Phudhichareonrat S. Oculopharyngodistal myopathy in a Thai family. J Med Assoc Thai. 2004;87:1518–21.
van der Sluijs BM, ter Laak HJ, Scheffer H, van der Maarel SM, van Engelen BG. Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity. J Neurol Neurosurg Psychiatry. 2004;75:1499–501.
Durmus H, Laval SH, Deymeer F, Parman Y, Kiyan E, Gokyigiti M, et al. Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology. 2011;76:227–35.
Google Scholar
Thevathasan W, Squier W, MacIver DH, Hilton DA, Fathers E, Hilton-Jones D. Oculopharyngodistal myopathy-a possible association with cardiomyopathy. Neuromuscul Disord. 2011;21:121–5.
Mignarri A, Carluccio MA, Malandrini A, Sicurelli F, Galli L, Mazzei MA, et al. The first Italian patient with oculopharyngodistal myopathy: case report and considerations on differential diagnosis. Neuromuscul Disord. 2012;22:759–62.
Kumutpongpanich T, Ogasawara M, Ozaki A, Ishiura H, Tsuji S, Minami N, et al. Clinicopathologic features of oculopharyngodistal myopathy with LRP12 CGG repeat expansions compared with other oculopharyngodistal myopathy subtypes. JAMA Neurol. 2021;78:853–63.
Saito R, Shimizu H, Miura T, Hara N, Mezaki N, Higuchi Y, et al. Oculopharyngodistal myopathy with coexisting histology of systemic neuronal intranuclear inclusion disease: clinicopathologic features of an autopsied patient harboring CGG repeat expansions in LRP12. Acta Neuropathol Commun. 2020;8:75.
Google Scholar
Ogasawara M, Eura N, Nagaoka U, Sato T, Arahata H, Hayashi T, et al. Intranuclear inclusions in skin biopsies are not limited to neuronal intranuclear inclusion disease but can also be seen in oculopharyngodistal myopathy. Neuropathol Appl Neurobiol. 2022;48:e12787.
Google Scholar
Fan Y, Shen S, Yang J, Yao D, Li M, Mao C, et al. GIPC1 CGG repeat expansion is associated with movement disorders. Ann Neurol. 2022;91:704–15.
Google Scholar
Amato AA, Jackson CE, Ridings LW, Barohn RJ. Childhood-onset oculopharyngodistal myopathy with chronic intestinal pseudo-obstruction. Muscle Nerve. 1995;18:842–7.
Google Scholar
Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology. 2012;79:1898–907.
